Harm Reduction Ohio announced a seven-person board of directors which will oversee and guide the organization in its pubic health and drug policy work.
“This board knows enormous amounts about harm reduction, both how it’s practiced and the policies and research that make it possible,” says Harm Reduction Ohio President Dennis Cauchon, who founded the organization in January 2017. “They will help lift Harm Reduction Ohio to a new level of effectiveness.”
Harm Reduction Ohio (HRO) is a 501(c)3 non-profit that advocates for drug policies based on science, health, compassion and human rights. HRO promotes approaches that — based on evidence — reduce mortality and improve the health and well-being of people who use drugs.
Harm Reduction Ohio also connects and supports harm reduction advocates from throughout Ohio in an effort to provide a statewide policy alternative to the drug war.
In addition to Cauchon, who will serve as a non-voting board member, Harm Reduction Ohio board members are:

Jose R. Rodriguez
Director of External Relations and Strategic Initiatives, Ohio State University College of Public Health, Columbus

Tasha Turner-Bicknell
DNP, RN, Assistant Professor of Clinical Nursing, University of Cincinnati College of Nursing

Laura Cash
Board Member/National Director of Chapters, GRASP (Grief Recovery After a Substance Passing) and Broken No More (substance use forum); Board Member, Ohio Change Addiction Now; M.A., Education, Delaware, Ohio

Anne C. Trinh
MPH, epidemiologist, Senior Program Manager – Opioid Administration, Ohio State University College of Public Health

Colleen (Maloney) Garlock
CDCA, CYT, RYT, medication-assisted treatment, case manager, Signature Health, Willoughby, Ohio

Janet N. Wray
PhD, RN, Associate Professor of Nursing, Division of Health Sciences, Mount St. Joseph University, Cincinnati

Dennis Cauchon
President and founder. Former national reporter, USA TODAY.
This is a tremendous idea. I wish you the best; many Ohioans will benefit from your efforts!!
Your board looks very qualified. We certainly need harm reduction now and even after we quit the failed War on Drugs. But until we quit the stupid war, the War on Drugs will actually impede your work to reduce the harm. There is no justification for impeding your efforts to advocate for drug policies based on science, compassion, health and human rights. I admire your group’s effort in this face of this resistance. Keep up the good work.